The availability of new and improved hepatitis C antiviral drug treatments has the potential to cure the virus with a single course of treatment lasting about 12 weeks. This is a drastic change ...
AbbVie has a new three-pronged drug hepatitis C regimen which analysts say could transform treatment of the disease. Another strong contender is Gilead's Sovaldi (sofosbuvir), which was launched ...
AbbVie has submitted its Hepatitis C treatment to the European regulator ... "This regulatory milestone, on the heels of our submission of a New Drug Application in the US, represents an important ...
Hepatitis C is a contagious liver disease ... their immune system is able to fight off the infection. But others may need treatment. Now, new treatments called Direct Antiviral Agents -- or ...
They are more likely to have complications and to die from hepatitis C. New antiviral treatments can cure hepatitis C and prevent complications like cirrhosis and liver cancer in most people.